Concepedia

Author

Rebecca Sutherland

University of OxfordORCID

Also Known As

A. Shepherd, H Hartley, I. Sutherland, R Sutherland, R. K. Sutherland, R. SUTHERLAND, R. Sutherland, R.K. Sutherland, RK Sutherland, Rajeka Lazarus

85

Publications

10.4K

Citations

19

H-Index

16

Concepts

All Affiliations

University of OxfordWestern General HospitalUniversity Hospitals Birmingham NHS Foundation TrustUniversity College LondonQueen Elizabeth University Hospital
RS

About

Rebecca Sutherland is an author at University of Oxford specializing in medicine, pharmacology, and antibiotics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

671

2

Pharmacology

4

4

116

3

Microbiology

2

2

30

4

Health Sciences

1

1

13

5

Hospital Medicine

1

1

555

Rebecca Sutherland

×

17

Publications

8.9K

Citations

15

H-Index

YearCitations

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi,

The Lancet

2020

5K

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi,

The Lancet

2021

1.2K

Oral versus Intravenous Antibiotics for Bone and Joint Infection

Ho Kwong Li, Ines Rombach, Rhea Zambellas,

New England Journal of Medicine

2019

850

Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial

Katherine R. W. Emary, Tanya Golubchik, Parvinder K. Aley,

The Lancet

2021

649

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi,

The Lancet

2021

555

Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002)

Amy Flaxman, Natalie G. Marchevsky, Daniel Jenkin,

The Lancet

2021

253

Oral versus intravenous antibiotics for bone and joint infections: the OVIVA non-inferiority RCT

Matthew Scarborough, Ho Kwong Li, Ines Rombach,

Health Technology Assessment

2019

71

Impaired IFN-γ-secreting capacity in mycobacterial antigen-specific CD4 T cells during chronic HIV-1 infection despite long-term HAART

Rebecca Sutherland, Hongbing Yang, Thomas J. Scriba,

AIDS

2006

70

-amino-p-hydroxybenzylpenicillin (BRL 2333), a new semisynthetic penicillin: absorption and excretion in man.

Croydon Ea, Rebecca Sutherland

PubMed

1970

60

Diagnosis and features of hospital-acquired pneumonia: a retrospective cohort study

Clark D Russell, Oliver Koch, Ian F. Laurenson,

Journal of Hospital Infection

2015

56

Page 1